EHA 2024 Recap: Optimizing the Relapsed/Refra...

Alarming in immunoglobulin A nephropathy (IgAN): over 40% present late. Explore latest advancements in management of the most common cause of primary glomerulonephritis worldwide. Credit available for this activity expires: 12/23/26 Earn Credit / Learning Objectives & Disclosures ...  Show more

How well are you managing patients on EGFR inhibitor therapies in your clinical practice? Credit available for this activity expires: 12/18/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/person-centered-care-egfr-mutated-advanced-nsclc-op ...  Show more

Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Lea ...  Show more

Are you up to date on your treatment approach to patients with postpartum depression? Credit available for this activity expires: 9/16/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/revolutionizing-postpartum-depression-care-expert-insigh ...  Show more

When you have a relapse in recovery, you can feel as though you are back to square one. A relapse is a normal part of the process of healing. In this episode, I explore how to manage and even embrace relapses (learning experiences!). I hope that you enjoy the episode.

  ...

Did you know that there are oral and nonoral treatments for migraine, along with non-pharmacologic options? Join our expert faculty to learn more. Credit available for this activity expires: 10/12/2023 Earn Credit / Learning Objectives & Disclosures:  https://www.medscape.org/view ...  Show more